title: Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat Walker 256 carcinosarcoma cells.
abstract: Bone is a major source of transforming growth factor-beta (TGF-beta), and a preferred target organ for metastasis of the rat Walker carcinosarcoma 256 (W256). Since chemotactic mechanisms may contribute to metastatic site specificity, we have tested the hypothesis that TGF-beta is a chemoattractant for these cancer cells. Purified platelet-derived TGF-beta elicited dose-dependent migration of W256 cells in the Boyden chamber assay with half-maximal responses (ED50) elicited by 0.12 +/- 0.01 ng TGF-beta/ml. Checkerboard analysis confirmed dependence of the response upon a concentration gradient. Conditioned media from organ cultures of bone contained TGF-beta and chemotactic activity in proportion to the extent of bone resorption. The chemotactic activity in conditioned bone culture medium and that of the purified platelet-derived TGF-beta were both inhibited after incubation with anti-TGF-beta 1. We conclude that TGF-beta, released from resorbing bone, can influence the migratory behavior of the osteotropic W256 cell line.
authors.affiliation: Department of Pathology, McMaster University, Hamilton, Ont., Canada.
authors.forename: F W
authors.initials: FW
authors.lastname: Orr
authors.forename: W
authors.initials: W
authors.lastname: Millar-Book
authors.forename: G
authors.initials: G
authors.lastname: Singh
mesh_terms: D000818:Animals; D001859:Bone Neoplasms / Q000556:secondary; D002279:Carcinoma 256, Walker / Q000473:pathology*; D002633:Chemotaxis; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009362:Neoplasm Metastasis; D051381:Rats; D011919:Rats, Inbred Strains; D015291:Transforming Growth Factors / Q000037:antagonists & inhibitors / Q000494:pharmacology*
chemical_list: D015291:Transforming Growth Factors